Medical technology firm Stryker has acquired Stanmore Implants Worldwide from SIW Holdings for about £35.6m.
Stanmore operates orthopaedic business that develops products, which will help surgeons to treat adult and juvenile orthopaedic oncology.
The company’s portfolio includes patient specific and off-the-shelf implant systems aimed at limb salvage.
Stryker orthopaedics group president David Floyd said: "The acquisition of Stanmore Implants provides Stryker with differentiated technologies designed to provide the most effective solutions for orthopaedic oncology surgeons.
"This addition underscores Stryker’s commitment to our core joint replacement business and expands our presence in the global orthopaedic oncology market."
Stanmore Implants CEO Michael Mainelli said: "The combination of Stryker’s commitment to orthopaedic oncology and Stanmore’s novel orthopaedic oncology solutions provides a unique opportunity to impact a broader group of patients globally."
In April, Stryker’s spine division purchased SafeWire product portfolio, which can be used in minimally-invasive spine procedures.
The purchased portfolio includes the Y-Wire guidewire and Tiger Jamshidi needle family for use in minimally invasive spine surgery.
With operations in around 100 countries, Stryker produces products in various segments such as orthopaedics, medical and surgical, and neurotechnology and spine.